Pitavastatin canada?

Availability of Pitavastatin in Canada
Pitavastatin is a prescription statin medication used to lower cholesterol levels and prevent cardiovascular disease. In Canada, pitavastatin was first approved by Health Canada in [1] (link to search at drugpatentwatch.com). However, its availability in pharmacies has been affected by patent issues and exclusivity agreements.

Licensing and Exclusivity Expirence
In 2019, Torrent Pharmaceuticals Limited gained marketing approval in Canada for pitavastatin under the brand name Livalo, marking the beginning of a new era in availability. As per current information, patent protection and exclusivity agreements restrict the entry of generic and biosimilar versions of pitavastatin in the Canadian market. As a result, patients may face varying prices for this medication.

Prices and Comparisons
Pricing of Livalo (pitavastatin) in Canada differs among pharmacies, but a search of average prices shows that they vary between $50 to over $100 for a month's supply. When comparing costs to other statins available in Canada, such as Atorvastatin and Simvastatin, Livalo falls within a similar price range. It is essential to consult a healthcare professional to determine the best statin for your condition and any potential out-of-pocket costs.

Alternative Options and Warranties
In cases where patients face financial burdens due to high Livalo costs, healthcare providers or patient organizations may consider alternative treatment options or help facilitate access to the medication.

Pitavastatin Availability and Potential Changes
As patent exclusivity and regulatory agreements are regularly reviewed, the availability and pricing of pitavastatin in Canada may undergo changes in the future. Patients and healthcare professionals should stay informed about these shifts to secure access to effective, affordable treatments.

Sources:

[1] www.drugpatentwatch.com - for information on pitavastatin patent expiry and exclusivity timelines.